BioNTech Financials

BioNTech Stock Summary

BioNTech competes with Dupont De, Park Electrochemical, Plaza Retail, Eastman Chemical, and Sumitomo Chemical. Neon Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in developing neoantigen-targeted therapies for cancers in the United States. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts. Neon Therapeutics operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 71 people.

BioNTech Key Financial Ratios

BioNTech Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BioNTech's current stock value. Our valuation model uses many indicators to compare BioNTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioNTech competition to find correlations between indicators driving BioNTech's intrinsic value. More Info.BioNTech is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioNTech's earnings, one of the primary drivers of an investment's value.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

If you are still planning to invest in BioNTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioNTech's history and understand the potential risks before investing.